bazedoxifene has been researched along with interleukin-8 in 2 studies
| Studies (bazedoxifene) | Trials (bazedoxifene) | Recent Studies (post-2010) (bazedoxifene) | Studies (interleukin-8) | Trials (interleukin-8) | Recent Studies (post-2010) (interleukin-8) |
|---|---|---|---|---|---|
| 307 | 69 | 249 | 23,523 | 1,167 | 9,990 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fu, S; Lin, J | 1 |
| Lin, J; Reader, J; Roque, DM; Zhang, R | 1 |
2 other study(ies) available for bazedoxifene and interleukin-8
| Article | Year |
|---|---|
Blocking Interleukin-6 and Interleukin-8 Signaling Inhibits Cell Viability, Colony-forming Activity, and Cell Migration in Human Triple-negative Breast Cancer and Pancreatic Cancer Cells.
Topics: Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Cyclobutanes; Drug Synergism; Female; Humans; Indoles; Interleukin-6; Interleukin-8; Neoplastic Stem Cells; Pancreatic Neoplasms; Signal Transduction; Sulfonamides; Triple Negative Breast Neoplasms | 2018 |
Combined inhibition of IL‑6 and IL‑8 pathways suppresses ovarian cancer cell viability and migration and tumor growth.
Topics: Animals; Benzamides; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclobutanes; Disease Models, Animal; Drug Therapy, Combination; Female; Humans; Indoles; Interleukin-6; Interleukin-8; Mice; Ovarian Neoplasms; Selective Estrogen Receptor Modulators | 2022 |